Effects of pioglitazone on lipid and lipoprotein profiles in patients with type 2 diabetes and dyslipidaemia after treatment conversion from rosiglitazone while continuing stable statin therapy. (Q51496275)
Jump to navigation
Jump to search
scientific article published in May 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of pioglitazone on lipid and lipoprotein profiles in patients with type 2 diabetes and dyslipidaemia after treatment conversion from rosiglitazone while continuing stable statin therapy. |
scientific article published in May 2006 |
Statements
Effects of pioglitazone on lipid and lipoprotein profiles in patients with type 2 diabetes and dyslipidaemia after treatment conversion from rosiglitazone while continuing stable statin therapy. (English)
1 reference
Paulos Berhanu
1 reference
Mark S Kipnes
1 reference
Mehmood A Khan
1 reference
Alfonso T Perez
1 reference
Stuart F Kupfer
1 reference
Robert C Spanheimer
1 reference
Seleshi Demissie
1 reference
Penny R Fleck
1 reference
1 May 2006
1 reference
3
1 reference
1
1 reference
39-44
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference